LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 34.50 | 770.25 | 3705 | 3712 | 0.9981 | 0.9983 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 36.73 | 770.25 | 3821 | 4086 | 0.9351 | 0.9450 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 36.73 | 770.25 | 4035 | 4086 | 0.9875 | 0.9896 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 38.95 | 770.25 | 4209 | 4543 | 0.9263 | 0.9411 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 38.95 | 770.25 | 4380 | 4543 | 0.9639 | 0.9715 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 41.17 | 770.25 | 4692 | 5010 | 0.9364 | 0.9520 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 41.17 | 770.25 | 4834 | 5010 | 0.9648 | 0.9736 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 43.39 | 770.25 | 5053 | 5404 | 0.9350 | 0.9527 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 43.39 | 770.25 | 5255 | 5404 | 0.9724 | 0.9802 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 45.61 | 770.25 | 5444 | 5813 | 0.9365 | 0.9555 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 45.61 | 770.25 | 5671 | 5813 | 0.9756 | 0.9831 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 47.83 | 770.25 | 5751 | 6223 | 0.9241 | 0.9483 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 47.83 | 770.25 | 6142 | 6223 | 0.9869 | 0.9913 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 50.05 | 770.25 | 6153 | 6629 | 0.9281 | 0.9525 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 50.05 | 770.25 | 6504 | 6629 | 0.9811 | 0.9877 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 52.27 | 770.25 | 6581 | 7058 | 0.9323 | 0.9566 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 52.27 | 770.25 | 6880 | 7058 | 0.9747 | 0.9840 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 54.49 | 770.25 | 7065 | 7555 | 0.9351 | 0.9597 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 54.49 | 770.25 | 7214 | 7555 | 0.9548 | 0.9721 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 56.71 | 770.25 | 7421 | 8001 | 0.9274 | 0.9559 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 56.71 | 770.25 | 7613 | 8001 | 0.9514 | 0.9707 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.94 | 770.25 | 7863 | 8444 | 0.9312 | 0.9591 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.94 | 770.25 | 8068 | 8444 | 0.9554 | 0.9738 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 61.16 | 770.25 | 8167 | 8892 | 0.9185 | 0.9524 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 61.16 | 770.25 | 8418 | 8892 | 0.9467 | 0.9692 | MN20160304_L02 | F06 |